Share Price and Basic Stock Data
Last Updated: January 23, 2026, 6:15 pm
| PEG Ratio | 1.83 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Deepak Chemtex Ltd operates in the Dyes & Pigments industry, with its shares currently priced at ₹108, resulting in a market capitalization of ₹117 Cr. The company has exhibited notable revenue growth, with reported sales increasing from ₹29.27 Cr in March 2021 to ₹68.00 Cr in March 2025. The trailing twelve months (TTM) sales stood at ₹62.28 Cr, reflecting a solid performance in the fiscal year. The latest quarterly sales figures indicate a robust Q1 FY2025, where sales rose to ₹35.29 Cr in March 2025, compared to ₹28.53 Cr in March 2024. This upward trajectory highlights the company’s ability to capitalize on market opportunities, indicating strong demand for its products in the dyes and pigments sector. Despite a dip to ₹26.99 Cr in September 2025, the overall trend suggests resilience and adaptability in a competitive landscape.
Profitability and Efficiency Metrics
Deepak Chemtex Ltd has demonstrated commendable profitability, with a net profit of ₹10.07 Cr reported for March 2025, reflecting a significant increase from ₹6.63 Cr in March 2024. The operating profit margin (OPM) has also shown improvement, rising to 19.09% in March 2025 from 17.13% in March 2024. This improvement in profitability is further supported by a healthy return on equity (ROE) of 20.9%, showcasing effective utilization of shareholders’ funds. The company’s interest coverage ratio (ICR) stood at an impressive 180.40x, indicating that interest obligations are comfortably covered by earnings. However, fluctuations in operating profit margin (OPM) from 15.11% in March 2024 to 16.92% in March 2025 suggest a need for continued focus on controlling expenses to maintain profitability amidst potential market volatility.
Balance Sheet Strength and Financial Ratios
Deepak Chemtex Ltd’s balance sheet reflects significant strength, with total assets reported at ₹64.32 Cr in March 2025 against borrowings of only ₹0.89 Cr, resulting in a minimal debt-to-equity ratio of 0.01. The company’s reserves have increased substantially to ₹42.66 Cr in March 2025 from ₹15.22 Cr in March 2023, indicating a solid accumulation of retained earnings. Additionally, the current ratio stands at a robust 3.29, suggesting strong liquidity to meet short-term obligations. The price-to-book value (P/BV) ratio is recorded at 2.16x, which is relatively high compared to typical sector norms, indicating that the stock may be trading at a premium. The return on capital employed (ROCE) of 28.1% further underscores the efficient deployment of capital in generating profits, enhancing overall financial stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Deepak Chemtex Ltd reveals a strong promoter holding of 73.05%, indicating significant confidence from the management in the company’s future prospects. The public holding stood at 26.94% as of September 2025, showcasing a well-distributed ownership structure. However, foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have shown negligible interest, with FIIs holding 0.00% and DIIs at 0.00%. This could reflect a lack of broader institutional confidence or awareness in the company’s potential. The number of shareholders has fluctuated, with 930 shareholders recorded in September 2025, down from 1,017 in March 2024. This decline may raise concerns about retail investor sentiment, given the importance of a diverse shareholder base in ensuring stability and confidence in the stock.
Outlook, Risks, and Final Insight
Looking ahead, Deepak Chemtex Ltd appears poised for continued growth, driven by its strong revenue trends and profitability metrics. However, risks remain, including potential volatility in raw material prices and competition within the dyes and pigments sector, which could impact margins. The company’s high reliance on promoter holding may limit market interest from institutional investors, hindering liquidity. Should the company manage to enhance its visibility and attract institutional investment, it could unlock further growth potential. Conversely, an inability to maintain profitability amidst rising operational costs or declining sales could pose a significant threat. Overall, while the company showcases many strengths, it must navigate these challenges effectively to sustain its upward trajectory and enhance shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Deepak Chemtex Ltd | 115 Cr. | 106 | 170/93.5 | 13.9 | 52.4 | 0.00 % | 28.1 % | 20.9 % | 10.0 |
| Prolife Industries Ltd | 25.4 Cr. | 62.0 | 273/62.0 | 10.5 | 115 | 0.48 % | 14.4 % | 10.8 % | 10.0 |
| Industry Average | 115.00 Cr | 84.00 | 12.20 | 83.70 | 0.24% | 21.25% | 15.85% | 10.00 |
Quarterly Result
| Metric | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|
| Sales | 28.53 | 32.71 | 35.29 | 26.99 |
| Expenses | 24.22 | 25.71 | 29.32 | 22.62 |
| Operating Profit | 4.31 | 7.00 | 5.97 | 4.37 |
| OPM % | 15.11% | 21.40% | 16.92% | 16.19% |
| Other Income | 0.80 | 0.72 | 1.79 | 0.80 |
| Interest | 0.00 | 0.07 | 0.03 | 0.04 |
| Depreciation | 0.41 | 0.74 | 0.87 | 0.72 |
| Profit before tax | 4.70 | 6.91 | 6.86 | 4.41 |
| Tax % | 25.74% | 24.02% | 29.74% | 22.45% |
| Net Profit | 3.48 | 5.25 | 4.82 | 3.43 |
| EPS in Rs | 3.20 | 4.83 | 4.44 | 3.16 |
Last Updated: December 27, 2025, 8:04 am
Below is a detailed analysis of the quarterly data for Deepak Chemtex Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 26.99 Cr.. The value appears to be declining and may need further review. It has decreased from 35.29 Cr. (Mar 2025) to 26.99 Cr., marking a decrease of 8.30 Cr..
- For Expenses, as of Sep 2025, the value is 22.62 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 29.32 Cr. (Mar 2025) to 22.62 Cr., marking a decrease of 6.70 Cr..
- For Operating Profit, as of Sep 2025, the value is 4.37 Cr.. The value appears to be declining and may need further review. It has decreased from 5.97 Cr. (Mar 2025) to 4.37 Cr., marking a decrease of 1.60 Cr..
- For OPM %, as of Sep 2025, the value is 16.19%. The value appears to be declining and may need further review. It has decreased from 16.92% (Mar 2025) to 16.19%, marking a decrease of 0.73%.
- For Other Income, as of Sep 2025, the value is 0.80 Cr.. The value appears to be declining and may need further review. It has decreased from 1.79 Cr. (Mar 2025) to 0.80 Cr., marking a decrease of 0.99 Cr..
- For Interest, as of Sep 2025, the value is 0.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.03 Cr. (Mar 2025) to 0.04 Cr., marking an increase of 0.01 Cr..
- For Depreciation, as of Sep 2025, the value is 0.72 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.87 Cr. (Mar 2025) to 0.72 Cr., marking a decrease of 0.15 Cr..
- For Profit before tax, as of Sep 2025, the value is 4.41 Cr.. The value appears to be declining and may need further review. It has decreased from 6.86 Cr. (Mar 2025) to 4.41 Cr., marking a decrease of 2.45 Cr..
- For Tax %, as of Sep 2025, the value is 22.45%. The value appears to be improving (decreasing) as expected. It has decreased from 29.74% (Mar 2025) to 22.45%, marking a decrease of 7.29%.
- For Net Profit, as of Sep 2025, the value is 3.43 Cr.. The value appears to be declining and may need further review. It has decreased from 4.82 Cr. (Mar 2025) to 3.43 Cr., marking a decrease of 1.39 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.16. The value appears to be declining and may need further review. It has decreased from 4.44 (Mar 2025) to 3.16, marking a decrease of 1.28.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:52 am
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Sales | 29.27 | 54.01 | 46.35 | 50.19 | 68.00 | 62.28 |
| Expenses | 25.08 | 47.74 | 38.54 | 41.59 | 55.02 | 51.94 |
| Operating Profit | 4.19 | 6.27 | 7.81 | 8.60 | 12.98 | 10.34 |
| OPM % | 14.31% | 11.61% | 16.85% | 17.13% | 19.09% | 16.60% |
| Other Income | 0.17 | 0.33 | 1.13 | 1.18 | 2.51 | 2.59 |
| Interest | 0.08 | 0.09 | 0.08 | 0.16 | 0.11 | 0.07 |
| Depreciation | 0.57 | 0.84 | 0.66 | 0.76 | 1.62 | 1.59 |
| Profit before tax | 3.71 | 5.67 | 8.20 | 8.86 | 13.76 | 11.27 |
| Tax % | 27.76% | 25.57% | 25.12% | 25.06% | 26.89% | |
| Net Profit | 2.67 | 4.22 | 6.15 | 6.63 | 10.07 | 8.25 |
| EPS in Rs | 6.10 | 9.27 | 7.60 | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|
| YoY Net Profit Growth (%) | 58.05% | 45.73% | 7.80% | 51.89% |
| Change in YoY Net Profit Growth (%) | 0.00% | -12.32% | -37.93% | 44.08% |
Deepak Chemtex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.
Growth
Last Updated: September 5, 2025, 3:11 pm
Balance Sheet
Last Updated: December 4, 2025, 2:43 am
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.50 | 0.50 | 0.50 | 10.86 | 10.86 | 10.86 |
| Reserves | 4.85 | 9.07 | 15.22 | 31.78 | 42.66 | 46.09 |
| Borrowings | 1.83 | 2.06 | 1.37 | 1.54 | 0.89 | 0.80 |
| Other Liabilities | 3.97 | 5.57 | 6.67 | 6.98 | 9.91 | 9.17 |
| Total Liabilities | 11.15 | 17.20 | 23.76 | 51.16 | 64.32 | 66.92 |
| Fixed Assets | 2.65 | 3.12 | 3.53 | 4.85 | 6.47 | 6.02 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.32 |
| Investments | 0.00 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 |
| Other Assets | 8.50 | 13.99 | 20.14 | 46.21 | 57.64 | 60.48 |
| Total Assets | 11.15 | 17.20 | 23.76 | 51.16 | 64.32 | 66.92 |
Below is a detailed analysis of the balance sheet data for Deepak Chemtex Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.86 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.86 Cr..
- For Reserves, as of Sep 2025, the value is 46.09 Cr.. The value appears strong and on an upward trend. It has increased from 42.66 Cr. (Mar 2025) to 46.09 Cr., marking an increase of 3.43 Cr..
- For Borrowings, as of Sep 2025, the value is 0.80 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.89 Cr. (Mar 2025) to 0.80 Cr., marking a decrease of 0.09 Cr..
- For Other Liabilities, as of Sep 2025, the value is 9.17 Cr.. The value appears to be improving (decreasing). It has decreased from 9.91 Cr. (Mar 2025) to 9.17 Cr., marking a decrease of 0.74 Cr..
- For Total Liabilities, as of Sep 2025, the value is 66.92 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 64.32 Cr. (Mar 2025) to 66.92 Cr., marking an increase of 2.60 Cr..
- For Fixed Assets, as of Sep 2025, the value is 6.02 Cr.. The value appears to be declining and may need further review. It has decreased from 6.47 Cr. (Mar 2025) to 6.02 Cr., marking a decrease of 0.45 Cr..
- For CWIP, as of Sep 2025, the value is 0.32 Cr.. The value appears strong and on an upward trend. It has increased from 0.11 Cr. (Mar 2025) to 0.32 Cr., marking an increase of 0.21 Cr..
- For Investments, as of Sep 2025, the value is 0.10 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.10 Cr..
- For Other Assets, as of Sep 2025, the value is 60.48 Cr.. The value appears strong and on an upward trend. It has increased from 57.64 Cr. (Mar 2025) to 60.48 Cr., marking an increase of 2.84 Cr..
- For Total Assets, as of Sep 2025, the value is 66.92 Cr.. The value appears strong and on an upward trend. It has increased from 64.32 Cr. (Mar 2025) to 66.92 Cr., marking an increase of 2.60 Cr..
Notably, the Reserves (46.09 Cr.) exceed the Borrowings (0.80 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Free Cash Flow | 2.36 | 4.21 | 6.44 | 7.06 | 12.09 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debtor Days | 65 | 57 | 88 | 110 | 90 |
| Inventory Days | 44 | 21 | 54 | 56 | 51 |
| Days Payable | 65 | 37 | 54 | 46 | 51 |
| Cash Conversion Cycle | 43 | 41 | 88 | 120 | 90 |
| Working Capital Days | 37 | 43 | 81 | 96 | 78 |
| ROCE % | 61% | 58% | 29% | 28% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 100.00 | 100.00 |
| Basic EPS (Rs.) | 11.51 | 6.71 | 7.90 | 5.30 |
| Diluted EPS (Rs.) | 11.51 | 6.71 | 7.90 | 5.30 |
| Cash EPS (Rs.) | 13.49 | 6.28 | 1396.53 | 956.65 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 50.75 | 38.62 | 3147.07 | 1882.56 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 50.75 | 38.62 | 3147.07 | 1882.56 |
| Revenue From Operations / Share (Rs.) | 73.13 | 45.43 | 9359.29 | 10843.42 |
| PBDIT / Share (Rs.) | 17.47 | 8.37 | 1835.07 | 1257.31 |
| PBIT / Share (Rs.) | 15.49 | 7.59 | 1703.10 | 1148.55 |
| PBT / Share (Rs.) | 15.39 | 7.56 | 1689.43 | 1129.59 |
| Net Profit / Share (Rs.) | 11.51 | 5.50 | 1264.56 | 847.89 |
| NP After MI And SOA / Share (Rs.) | 11.38 | 5.50 | 1264.56 | 847.89 |
| PBDIT Margin (%) | 23.88 | 18.43 | 19.60 | 11.59 |
| PBIT Margin (%) | 21.18 | 16.70 | 18.19 | 10.59 |
| PBT Margin (%) | 21.05 | 16.63 | 18.05 | 10.41 |
| Net Profit Margin (%) | 15.74 | 12.10 | 13.51 | 7.81 |
| NP After MI And SOA Margin (%) | 15.55 | 12.10 | 13.51 | 7.81 |
| Return on Networth / Equity (%) | 22.41 | 14.23 | 40.20 | 45.08 |
| Return on Capital Employeed (%) | 29.89 | 19.48 | 53.05 | 58.05 |
| Return On Assets (%) | 17.54 | 11.72 | 26.48 | 24.66 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.02 |
| Total Debt / Equity (X) | 0.01 | 0.03 | 0.08 | 0.21 |
| Asset Turnover Ratio (%) | 1.31 | 1.32 | 2.28 | 0.00 |
| Current Ratio (X) | 3.29 | 4.98 | 2.44 | 1.92 |
| Quick Ratio (X) | 2.50 | 4.22 | 1.89 | 1.62 |
| Inventory Turnover Ratio (X) | 8.94 | 5.40 | 8.32 | 0.00 |
| Interest Coverage Ratio (X) | 180.40 | 257.73 | 134.27 | 66.32 |
| Interest Coverage Ratio (Post Tax) (X) | 119.91 | 170.20 | 93.52 | 45.73 |
| Enterprise Value (Cr.) | 114.22 | 53.62 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 1.44 | 1.09 | 0.00 | 0.00 |
| EV / EBITDA (X) | 6.02 | 5.89 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 1.50 | 1.45 | 0.00 | 0.00 |
| Price / BV (X) | 2.16 | 1.71 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 1.50 | 1.45 | 0.00 | 0.00 |
| EarningsYield | 0.10 | 0.08 | 0.00 | 0.00 |
After reviewing the key financial ratios for Deepak Chemtex Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.51. This value is within the healthy range. It has increased from 6.71 (Mar 24) to 11.51, marking an increase of 4.80.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.51. This value is within the healthy range. It has increased from 6.71 (Mar 24) to 11.51, marking an increase of 4.80.
- For Cash EPS (Rs.), as of Mar 25, the value is 13.49. This value is within the healthy range. It has increased from 6.28 (Mar 24) to 13.49, marking an increase of 7.21.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 50.75. It has increased from 38.62 (Mar 24) to 50.75, marking an increase of 12.13.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 50.75. It has increased from 38.62 (Mar 24) to 50.75, marking an increase of 12.13.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 73.13. It has increased from 45.43 (Mar 24) to 73.13, marking an increase of 27.70.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 17.47. This value is within the healthy range. It has increased from 8.37 (Mar 24) to 17.47, marking an increase of 9.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is 15.49. This value is within the healthy range. It has increased from 7.59 (Mar 24) to 15.49, marking an increase of 7.90.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.39. This value is within the healthy range. It has increased from 7.56 (Mar 24) to 15.39, marking an increase of 7.83.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.51. This value is within the healthy range. It has increased from 5.50 (Mar 24) to 11.51, marking an increase of 6.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.38. This value is within the healthy range. It has increased from 5.50 (Mar 24) to 11.38, marking an increase of 5.88.
- For PBDIT Margin (%), as of Mar 25, the value is 23.88. This value is within the healthy range. It has increased from 18.43 (Mar 24) to 23.88, marking an increase of 5.45.
- For PBIT Margin (%), as of Mar 25, the value is 21.18. This value exceeds the healthy maximum of 20. It has increased from 16.70 (Mar 24) to 21.18, marking an increase of 4.48.
- For PBT Margin (%), as of Mar 25, the value is 21.05. This value is within the healthy range. It has increased from 16.63 (Mar 24) to 21.05, marking an increase of 4.42.
- For Net Profit Margin (%), as of Mar 25, the value is 15.74. This value exceeds the healthy maximum of 10. It has increased from 12.10 (Mar 24) to 15.74, marking an increase of 3.64.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 12.10 (Mar 24) to 15.55, marking an increase of 3.45.
- For Return on Networth / Equity (%), as of Mar 25, the value is 22.41. This value is within the healthy range. It has increased from 14.23 (Mar 24) to 22.41, marking an increase of 8.18.
- For Return on Capital Employeed (%), as of Mar 25, the value is 29.89. This value is within the healthy range. It has increased from 19.48 (Mar 24) to 29.89, marking an increase of 10.41.
- For Return On Assets (%), as of Mar 25, the value is 17.54. This value is within the healthy range. It has increased from 11.72 (Mar 24) to 17.54, marking an increase of 5.82.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.31. It has decreased from 1.32 (Mar 24) to 1.31, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 3.29. This value exceeds the healthy maximum of 3. It has decreased from 4.98 (Mar 24) to 3.29, marking a decrease of 1.69.
- For Quick Ratio (X), as of Mar 25, the value is 2.50. This value exceeds the healthy maximum of 2. It has decreased from 4.22 (Mar 24) to 2.50, marking a decrease of 1.72.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.94. This value exceeds the healthy maximum of 8. It has increased from 5.40 (Mar 24) to 8.94, marking an increase of 3.54.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 180.40. This value is within the healthy range. It has decreased from 257.73 (Mar 24) to 180.40, marking a decrease of 77.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 119.91. This value is within the healthy range. It has decreased from 170.20 (Mar 24) to 119.91, marking a decrease of 50.29.
- For Enterprise Value (Cr.), as of Mar 25, the value is 114.22. It has increased from 53.62 (Mar 24) to 114.22, marking an increase of 60.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has increased from 1.09 (Mar 24) to 1.44, marking an increase of 0.35.
- For EV / EBITDA (X), as of Mar 25, the value is 6.02. This value is within the healthy range. It has increased from 5.89 (Mar 24) to 6.02, marking an increase of 0.13.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.45 (Mar 24) to 1.50, marking an increase of 0.05.
- For Price / BV (X), as of Mar 25, the value is 2.16. This value is within the healthy range. It has increased from 1.71 (Mar 24) to 2.16, marking an increase of 0.45.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.45 (Mar 24) to 1.50, marking an increase of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has increased from 0.08 (Mar 24) to 0.10, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Deepak Chemtex Ltd:
- Net Profit Margin: 15.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 29.89% (Industry Average ROCE: 21.25%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 22.41% (Industry Average ROE: 15.85%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 119.91
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.5
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.9 (Industry average Stock P/E: 12.2)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.74%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | Aawashi, 28/1A, A/P Adgul Aawashi, Ratnagiri Maharashtra 415722 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Saurbah Deepak Arora | Chairman & Managing Director |
| Mrs. Trishla Baid | WholeTime Director & CFO |
| Mr. Rajesh Kalikaprasad Tiwari | Executive Director |
| Mr. Narendra Kumar Baid | Non Executive Director |
| Mr. Gautam Lath | Independent Director |
| Mrs. Pinki Kedia | Independent Director |
FAQ
What is the intrinsic value of Deepak Chemtex Ltd?
Deepak Chemtex Ltd's intrinsic value (as of 26 January 2026) is ₹133.67 which is 26.10% higher the current market price of ₹106.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹115 Cr. market cap, FY2025-2026 high/low of ₹170/93.5, reserves of ₹46.09 Cr, and liabilities of ₹66.92 Cr.
What is the Market Cap of Deepak Chemtex Ltd?
The Market Cap of Deepak Chemtex Ltd is 115 Cr..
What is the current Stock Price of Deepak Chemtex Ltd as on 26 January 2026?
The current stock price of Deepak Chemtex Ltd as on 26 January 2026 is ₹106.
What is the High / Low of Deepak Chemtex Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Deepak Chemtex Ltd stocks is ₹170/93.5.
What is the Stock P/E of Deepak Chemtex Ltd?
The Stock P/E of Deepak Chemtex Ltd is 13.9.
What is the Book Value of Deepak Chemtex Ltd?
The Book Value of Deepak Chemtex Ltd is 52.4.
What is the Dividend Yield of Deepak Chemtex Ltd?
The Dividend Yield of Deepak Chemtex Ltd is 0.00 %.
What is the ROCE of Deepak Chemtex Ltd?
The ROCE of Deepak Chemtex Ltd is 28.1 %.
What is the ROE of Deepak Chemtex Ltd?
The ROE of Deepak Chemtex Ltd is 20.9 %.
What is the Face Value of Deepak Chemtex Ltd?
The Face Value of Deepak Chemtex Ltd is 10.0.